Lippo Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Lippo hat ein Gesamteigenkapital von HK$12.9B und eine Gesamtverschuldung von HK$1.6B, was einen Verschuldungsgrad von 12.7% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen HK$15.1B bzw. HK$2.2B.

Wichtige Informationen

12.7%

Verhältnis von Schulden zu Eigenkapital

HK$1.64b

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	HK$758.91m
Eigenkapital	HK$12.91b
Gesamtverbindlichkeiten	HK$2.22b
Gesamtvermögen	HK$15.13b

Jüngste Berichte zur Finanzlage

Recent updates

We Think Some Shareholders May Hesitate To Increase Lippo Limited's (HKG:226) CEO Compensation

May 30

Is Lippo (HKG:226) A Risky Investment?

Oct 28

We Think Lippo (HKG:226) Has A Fair Chunk Of Debt

Apr 26

Zooming in on HKG:226's 4.0% Dividend Yield

Mar 22

How Much Does Lippo's (HKG:226) CEO Make?

Feb 15

Lippo's(HKG:226) Share Price Is Down 50% Over The Past Three Years.

Jan 19

Is Lippo (HKG:226) A Risky Investment?

Dec 24

Tread With Caution Around Lippo Limited's (HKG:226) 3.9% Dividend Yield

Nov 28

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 226Die kurzfristigen Aktiva des Unternehmens (HK$1.0B) übersteigen seine kurzfristigen Passiva (HK$786.5M).

Langfristige Verbindlichkeiten: 226Die kurzfristigen Vermögenswerte des Unternehmens (HK$1.0B) decken seine langfristigen Verbindlichkeiten (HK$1.4B) nicht.

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 226Die Nettoverschuldung im Verhältnis zum Eigenkapital (6.8%) wird als zufriedenstellend angesehen.

Schulden abbauen: 226 Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 17.9% auf 12.7% zurückgegangen.

Schuldendeckung: 226Der operative Cashflow des Unternehmens ist negativ, so dass die Schulden nicht ausreichend gedeckt sind.

Zinsdeckung: Es liegen nicht genügend Daten vor, um festzustellen, ob die Zinszahlungen von 226 auf seine Schulden durch EBIT gut gedeckt sind.

Lippo Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Is Lippo (HKG:226) A Risky Investment?

We Think Lippo (HKG:226) Has A Fair Chunk Of Debt

Is Lippo (HKG:226) A Risky Investment?

Recent updates

Lippo Limited Announces Chief Executive Officer Changes, Effective from 7 June 2024

We Think Some Shareholders May Hesitate To Increase Lippo Limited's (HKG:226) CEO Compensation

Lippo Limited, Annual General Meeting, Jun 06, 2024

Full year 2023 earnings released: HK$0.07 loss per share (vs HK$0.25 profit in FY 2022)

Lippo Limited to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Is Lippo (HKG:226) A Risky Investment?

First half 2023 earnings released: EPS: HK$0.005 (vs HK$0.21 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.005 (vs HK$0.21 in 1H 2022)

New minor risk - Earnings quality

Lippo Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Lippo Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Lippo Limited to Report First Half, 2023 Results on Aug 30, 2023

Full year 2022 earnings released: EPS: HK$0.25 (vs HK$1.01 in FY 2021)

Less than half of directors are independent

Lippo Limited Announces Change of Independent Non-Executive Director- and Composition of Board Committees

Less than half of directors are independent

First half 2022 earnings released

First half 2022 earnings released: EPS: HK$0.21 (vs HK$0.24 in 1H 2021)

Lippo Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022

Lippo Limited to Report First Half, 2022 Results on Aug 30, 2022

Lippo Limited Approves Final Dividend for the Year Ended December 31, 2022

Upcoming dividend of HK$0.04 per share

Less than half of directors are independent

Lippo Limited, Annual General Meeting, Jun 08, 2022

Full year 2021 earnings released: EPS: HK$1.01 (vs HK$2.19 loss in FY 2020)

Lippo Limited Proposes Final Dividend for the Year Ended 31 December 2021, Payable on or About 29 June 2022

Lippo Limited to Report Fiscal Year 2021 Final Results on Mar 31, 2022

Upcoming dividend of HK$0.03 per share

Lippo Limited Proposes Final Dividend for the Nine Months Ended 31 December 2020

We Think Lippo (HKG:226) Has A Fair Chunk Of Debt

Zooming in on HKG:226's 4.0% Dividend Yield

Lippo Limited to Report Nine Months, 2021 Results on Mar 30, 2021

How Much Does Lippo's (HKG:226) CEO Make?

Lippo's(HKG:226) Share Price Is Down 50% Over The Past Three Years.

First half 2021 earnings released: HK$1.30 loss per share

New 90-day high: HK$2.48

Is Lippo (HKG:226) A Risky Investment?

First half 2021 earnings released: HK$1.30 loss per share

Tread With Caution Around Lippo Limited's (HKG:226) 3.9% Dividend Yield

Lippo Limited to Report First Half, 2021 Results on Nov 27, 2020

New 90-day low: HK$2.04

New 90-day low: HK$2.06

New 90-day low - HK$2.22

Full year earnings released - HK$0.021 loss per share

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen